AGTR1 and atrial fibrillation: However, while indirect evidence from numerous clinical trials indicated that chronic inhibition of AT1 receptor signaling significantly reduces the incidence of AF, large randomized trials failed to demonstrate the beneficial effects of AT1 antagonists on AF [27,28,29].